Haemonetics Corp. buy BTIG Research
Start price
21.11.25
/
50%
€67.50
Target price
21.11.26
€76.29
Performance (%)
0.74%
Price
26.06.26
€68.00
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Haemonetics Corp. is nearly unchanged. This prediction currently runs until 21.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 5.426% | 5.426% |
| iShares Core DAX® | -1,36 % | -2,33 % |
| iShares Nasdaq 100 | -3,70 % | -1,24 % |
| iShares Nikkei 225® | -2,51 % | 6,91 % |
| iShares S&P 500 | -1,66 % | -0,64 % |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
40.50%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-5.56%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
18.26%
26.06.26
26.06.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25